CN Stock MarketDetailed Quotes
002286 Baolingbao Biology
- 7.49
- +0.38+5.34%
Not Open Nov 7 15:00 CST
2.77BMarket Cap25.39P/E (TTM)
7.55High7.07Low146.15KlotVolume7.11Open7.11Pre Close107.89MTurnover3.95%Turnover Ratio51.30P/E (Static)369.77MShares8.3252wk High1.36P/B2.77BFloat Cap4.5552wk Low7.82Limit Up369.59MShs Float25.49Historical High6.40Limit Down6.75%Amplitude4.16Historical Low0.08Dividend TTM7.38Avg Price53.43KlotAsk1.07%Div YieldTTM100Lot Size91.19KlotBid
Baolingbao Biology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -6.70%1.83B | -7.49%1.19B | -9.68%551.22M | -6.96%2.52B | -5.56%1.97B | -7.32%1.28B | -7.22%610.27M | -1.89%2.71B | 0.19%2.08B | 9.61%1.38B |
| Operating revenue | -6.70%1.83B | -7.49%1.19B | -9.68%551.22M | -6.96%2.52B | -5.56%1.97B | -7.32%1.28B | -7.22%610.27M | -1.89%2.71B | 0.19%2.08B | 9.61%1.38B |
| Other operating revenue | ---- | 15.92%3.89M | ---- | -20.20%7.65M | ---- | -22.94%3.36M | ---- | -3.16%9.59M | ---- | 22.82%4.36M |
| Total operating cost | -10.37%1.72B | -11.53%1.11B | -11.12%527.52M | -3.71%2.47B | -2.06%1.92B | -2.07%1.26B | -2.94%593.49M | 0.09%2.57B | 2.61%1.96B | 7.11%1.28B |
| Operating cost | -8.94%1.62B | -10.25%1.05B | -9.14%496.21M | -3.36%2.32B | -3.57%1.78B | -3.58%1.16B | -4.51%546.12M | 0.21%2.4B | 2.72%1.84B | 7.86%1.21B |
| Operating tax surcharges | 19.03%13.57M | 22.01%8.72M | 57.65%4.19M | -1.22%15.84M | 6.78%11.4M | 15.11%7.15M | -16.75%2.66M | -2.01%16.04M | -14.31%10.68M | -9.64%6.21M |
| Operating expense | -9.76%28.3M | 2.86%18.51M | 18.82%8.42M | -2.79%35.77M | 15.11%31.36M | 0.45%18M | -22.86%7.09M | 8.51%36.79M | -8.60%27.24M | -1.59%17.92M |
| Administration expense | -36.45%53.14M | -37.25%32.91M | -43.36%16.28M | -23.95%70.73M | 15.99%83.61M | 27.05%52.45M | 50.95%28.74M | 5.38%93M | 25.81%72.09M | -1.22%41.28M |
| Financial expense | -68.91%4.19M | -85.94%1.34M | -86.79%935.93K | 53.00%17.17M | 212.89%13.49M | 78.30%9.5M | 13.64%7.09M | -34.60%11.22M | -54.33%4.31M | -11.31%5.33M |
| -Interest expense (Financial expense) | -47.63%9.92M | -52.85%6.54M | -39.44%3.34M | -14.55%22.68M | -8.34%18.94M | 4.89%13.87M | -2.54%5.51M | 56.58%26.54M | 50.03%20.67M | 49.86%13.22M |
| -Interest Income (Financial expense) | 21.33%-3.19M | 22.22%-1.9M | -224.89%-1.3M | -17.08%-5.45M | -16.41%-4.06M | -9.14%-2.44M | 73.75%-398.64K | 3.24%-4.66M | -0.34%-3.48M | -5.13%-2.23M |
| Research and development | 1.83%6.58M | 4.59%4.01M | -17.61%1.48M | 33.57%11.3M | -3.43%6.46M | 10.00%3.84M | -4.65%1.79M | -32.76%8.46M | -38.18%6.69M | -17.78%3.49M |
| Credit Impairment Loss | 128.97%446.82K | 85.85%-324.86K | 328.26%1.39M | -342.22%-5.73M | -201.20%-1.54M | -226.26%-2.3M | 47.62%-610.04K | 196.13%2.37M | 157.09%1.52M | -135.91%-703.77K |
| Asset Impairment Loss | 75.38%-1.53M | 42.42%-1.89M | 78.74%-407.07K | -58.97%-7.02M | -676.17%-6.23M | -573.56%-3.29M | -1,085.82%-1.91M | -127.09%-4.41M | 36.33%-802.66K | 59.93%-488.34K |
| Other net revenue | -22.99%9.92M | -42.55%7.72M | 36.87%5.91M | -20.51%10.28M | -16.12%12.88M | 47.63%13.45M | -17.06%4.31M | -61.97%12.94M | -31.13%15.36M | -23.70%9.11M |
| Fair value change income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -76.74%2.61M | -63.52%2.57M | 1,996.67%2.52M |
| Invest income | -27.20%2.31M | -9.57%2.72M | -21.64%1.59M | -42.53%1.9M | -8.61%3.18M | -10.42%3M | 4.49%2.03M | -76.41%3.31M | -63.54%3.48M | -53.04%3.35M |
| -Including: Investment income associates | -19.33%2.31M | 0.84%2.72M | -7.50%1.59M | -24.74%1.62M | -21.05%2.87M | -19.67%2.69M | -11.48%1.72M | 324.06%2.15M | 4.22%3.63M | 328.82%3.35M |
| Asset deal income | --401.54K | --401.46K | --400.93K | -9.27%-49.25K | ---- | ---- | ---- | ---45.07K | ---45.07K | --28.51K |
| Other revenue | -52.55%8.29M | -57.41%6.83M | -39.10%2.93M | 132.63%21.18M | 102.33%17.48M | 264.57%16.03M | 165.72%4.81M | -30.78%9.1M | -10.56%8.64M | -31.78%4.4M |
| Operating profit | 115.98%120.53M | 109.57%82.35M | 40.38%29.61M | -60.05%64.01M | -58.18%55.8M | -64.16%39.29M | -59.06%21.09M | -32.09%160.23M | -28.45%133.45M | 43.58%109.64M |
| Add:Non operating Income | -69.49%268.73K | -84.10%138.39K | 971.84%91.75K | 730.95%1.12M | 536.16%880.79K | 608.96%870.62K | 103.81%8.56K | -85.29%134.6K | 18.98%138.45K | 25.21%122.8K |
| Less:Non operating expense | 1,338.21%606.13K | 18,298.91%210.22K | 209,421.24%2.08M | -99.69%11.56K | -96.90%42.14K | -99.89%1.14K | -99.90%991.28 | 3,312.20%3.67M | 7,527.69%1.36M | 10,129.01%1.02M |
| Total profit | 112.19%120.19M | 104.85%82.28M | 30.92%27.63M | -58.44%65.11M | -57.16%56.64M | -63.07%40.16M | -58.24%21.1M | -33.81%156.69M | -29.14%132.23M | 42.24%108.74M |
| Less:Income tax cost | 79.43%19.12M | 74.81%12.94M | 10.02%4.46M | -52.61%11.15M | -50.79%10.66M | -58.84%7.41M | -48.07%4.05M | -33.10%23.52M | -17.62%21.65M | 51.09%17.99M |
| Net profit | 119.78%101.07M | 111.64%69.33M | 35.89%23.17M | -59.47%53.97M | -58.41%45.99M | -63.90%32.76M | -60.09%17.05M | -33.94%133.17M | -31.03%110.58M | 40.60%90.75M |
| Net profit from continuing operation | 119.78%101.07M | 111.64%69.33M | 35.89%23.17M | -59.47%53.97M | -58.41%45.99M | -63.90%32.76M | -60.09%17.05M | -33.94%133.17M | -31.03%110.58M | 40.60%90.75M |
| Net profit of parent company owners | 119.78%101.07M | 111.64%69.33M | 35.89%23.17M | -59.47%53.97M | -58.41%45.99M | -63.90%32.76M | -60.09%17.05M | -33.94%133.17M | -31.03%110.58M | 40.60%90.75M |
| Earning per share | ||||||||||
| Basic earning per share | 125.00%0.27 | 111.11%0.19 | 20.00%0.06 | -58.33%0.15 | -50.00%0.12 | -62.50%0.09 | -54.55%0.05 | -33.33%0.36 | -44.19%0.24 | 41.18%0.24 |
| Diluted earning per share | 125.00%0.27 | 111.11%0.19 | 20.00%0.06 | -58.33%0.15 | -50.00%0.12 | -62.50%0.09 | -54.55%0.05 | -33.33%0.36 | -44.19%0.24 | 41.18%0.24 |
| Other composite income | 8.33%-20.36M | -2,050.95%-24.86M | -237.77%-21.45M | -158.82%-39.4M | -31.35%-22.21M | 107.54%1.27M | 220.34%15.57M | 130.56%66.98M | -1,760.48%-16.91M | -899.00%-16.91M |
| Other composite income of parent company owners | 8.33%-20.36M | -2,050.95%-24.86M | -237.77%-21.45M | -158.82%-39.4M | -31.35%-22.21M | 107.54%1.27M | 220.34%15.57M | 130.56%66.98M | -1,760.48%-16.91M | -899.00%-16.91M |
| Total composite income | 239.46%80.71M | 30.68%44.47M | -94.74%1.72M | -92.72%14.57M | -74.62%23.78M | -53.91%34.03M | 9.52%32.62M | -13.22%200.14M | -41.24%93.67M | 17.48%73.84M |
| Total composite income of parent company owners | 239.46%80.71M | 30.68%44.47M | -94.74%1.72M | -92.72%14.57M | -74.62%23.78M | -53.91%34.03M | 9.52%32.62M | -13.22%200.14M | -41.24%93.67M | 17.48%73.84M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Hexin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Hexin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data